SELLAS Life Sciences
SLS
#4150
Rank
โ‚น258.03 B
Marketcap
โ‚น1,266
Share price
-8.08%
Change (1 day)
823.38%
Change (1 year)

Earnings for SELLAS Life Sciences (SLS)

Earnings in 2026 (TTM): -โ‚น3.25 Billion

According to SELLAS Life Sciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น2.62 Billion, an increase over its 2024 earnings that were of -โ‚น2.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SELLAS Life Sciences from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.25 Billion23.83%
2025 -โ‚น2.62 Billion-10.28%
2024 -โ‚น2.92 Billion-16.78%
2023 -โ‚น3.51 Billion-9.73%
2022 -โ‚น3.89 Billion65.85%
2021 -โ‚น2.35 Billion48.95%
2020 -โ‚น1.58 Billion-1.31%
2019 -โ‚น1.6 Billion-44.65%
2018 -โ‚น2.89 Billion45.99%
2017 -โ‚น1.98 Billion-33.17%
2016 -โ‚น2.96 Billion-6.87%
2015 -โ‚น3.18 Billion-30.98%
2014 -โ‚น4.6 Billion46.52%
2013 -โ‚น3.14 Billion
2011 -โ‚น1.56 Billion
2008 -โ‚น1.35 Billion27.51%
2007 -โ‚น1.06 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion 343.33%๐Ÿ‡บ๐Ÿ‡ธ USA